MILAN , Nov. 21, 2024 /PRNewswire/ -- H.I.
G. Capital ("H.I.
G."), a leading global alternative investment firm with $66 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, Deenova S.r.
l. ("Deenova" or the "Company"), a leading Italian company in the field of traceability of drugs and medical devices in European hospitals. The Company is being purchased by Equiter Infrastructure II, a fund managed by Ersel Asset Management SGR, and Amundi Private Equity Italia ("APEI"), in partnership with Deenova's founder Sergio Giglio .
The close of the transaction is subject to customary, regulatory approvals. Since 2004, Deenova has been providing value-add automation and traceability services for hospitals by designing, implementing, and operating automatic distribution and tracking systems for drugs and medical devices. Deenova is a long-term partner solution for hospitals, implementing fully integrated systems with hospital infrastructure, and guaranteeing significant benefits in terms of patient safety, cost savings, and process optimization.
Since its initial investment, H.I.G.
has supported Deenova's international growth through strategic acquisitions and the strengthening of its management team. The Company has become an industry leader throughout Europe , with a current presence in approximately 100 hospitals in Italy , France , United Kingdom , Malta , Germany , Spain , and Poland . Raffaele.
